Education
About Us
Working with TipRanks
Follow Us
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
ORCHPHARMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹603.80 - ₹1,998.00
Previous CloseN/A
Volume34.10K
Average Volume (3M)7.09K
Market Cap
₹37.99B
Enterprise Value₹39.06B
Total Cash (Recent Filing)₹2.44B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)37.7
Beta1.39
Next Earnings
Aug 07, 2025EPS Estimate
3.7Last Dividend Ex-Date
Sep 13, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)4.40
Shares Outstanding50,719,105
10 Day Avg. Volume5,006
30 Day Avg. Volume7,091
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)2.96
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ORCHPHARMA FAQ
What was Orchid Pharma Limited’s price range in the past 12 months?
Orchid Pharma Limited lowest stock price was ₹603.80 and its highest was ₹1998.00 in the past 12 months.
What is Orchid Pharma Limited’s market cap?
Orchid Pharma Limited’s market cap is ₹37.99B.
When is Orchid Pharma Limited’s upcoming earnings report date?
Orchid Pharma Limited’s upcoming earnings report date is Aug 07, 2025 which is in 20 days.
How were Orchid Pharma Limited’s earnings last quarter?
Orchid Pharma Limited released its earnings results on May 26, 2025. The company reported ₹4.4 earnings per share for the quarter, the consensus estimate of ₹4.4 by ₹0.
Is Orchid Pharma Limited overvalued?
According to Wall Street analysts Orchid Pharma Limited’s price is currently Overvalued.
Does Orchid Pharma Limited pay dividends?
Orchid Pharma Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of N/A. See more information on Orchid Pharma Limited dividends here
What is Orchid Pharma Limited’s EPS estimate?
Orchid Pharma Limited’s EPS estimate is 3.7.
How many shares outstanding does Orchid Pharma Limited have?
Orchid Pharma Limited has 50,719,105 shares outstanding.
What happened to Orchid Pharma Limited’s price movement after its last earnings report?
Orchid Pharma Limited reported an EPS of ₹4.4 in its last earnings report, expectations of ₹4.4. Following the earnings report the stock price went down -1.776%.
Which hedge fund is a major shareholder of Orchid Pharma Limited?
Currently, no hedge funds are holding shares in IN:ORCHPHARMA
Company Description
Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Gufic Biosciences Limited
―
Morepen Laboratories Limited
―
RPG Life Sciences Limited
―
Gujarat Themis Biosyn Ltd
―